4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000904454-13-000201
Options or other derivatives
- SVP & Chief Medical Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gelder Mark S. MD · SVP & Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-02-08 | Grant or award : show line 1 in the form Stock Option (right to buy) | +75,000 | $0.75 | 2023-02-08 | 75,000 | 75,000 | D |
Loading xslF345X03/edgar.xml…